Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LykisBOM:530689 +1.15%67 EBITDA Margin % is 3.64% as of Mar. 2026, which is 66% above its 10-year median of 2.19. GuruFocus rates BOM:530689 with a GF Score™ of 67/100 and a GF Value™ of ₹50.89 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,955 Consumer Packaged Goods companies, Lykis ranks worse than 73.55% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lykis's EBITDA for the
three
months ended in Mar. 2026 was ₹53 Mil. Lykis's Revenue for the
three
months ended in Mar. 2026 was ₹1,454 Mil. Therefore, Lykis's EBITDA margin for the quarter that ended in Mar. 2026 was 3.64%.
Lykis (BOM:530689) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Lykis EBITDA Margin % Related Terms
Lykis EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Lykis's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530689 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Lykis's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lykis EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Lykis's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Lykis's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lykis (BOM:530689) has a EBITDA Margin % of 3.64% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lykis and its competitors. This is 66% above median its historical median of 2.19. According to the industry distribution chart, Lykis ranks #1438 out of 1955 companies in the Consumer Packaged Goods industry, placing it in the top 73.6%.
Is Lykis' EBITDA Margin % too high?
Lykis' current EBITDA Margin % of 3.64% is 66% above median its 10-year median of 2.19. The Consumer Packaged Goods industry median EBITDA Margin % is 9.00. Lykis' value of 3.64% is 59.6% below this industry median. Based on the distribution chart, Lykis ranks #1438 out of 1955 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Lykis has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lykis' EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Lykis ranks #1438 out of 1955 companies for EBITDA Margin %. This places Lykis in the lower half of its industry. The industry median EBITDA Margin % is 9.00. Lykis' value of 3.64% is 59.6% below this benchmark. While the company's 10-year median is 2.19 vs. the industry median of 9.00, Lykis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.00, based on 1,955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lykis's current EBITDA Margin % of 3.64% is 59.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lykis and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lykis's current EBITDA Margin % is 3.64%, which is 66% above median its own 10-year median of 2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lykis stock overvalued right now?
Based on GuruFocus' analysis, Lykis (BOM:530689) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹50.89, compared to a current price of ₹45.93 — trading 9.7% below its estimated fair value. The current EBITDA Margin % is 3.64%, which is 66% above median its 10-year median of 2.19 and 59.6% below the Consumer Packaged Goods industry median of 9.00. Lykis' overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Lykis (BOM:530689), the current EBITDA Margin % is 3.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lykis (BOM:530689) Overvalued in 2026?
Based on GuruFocus' analysis, Lykis stock appears to be undervalued.
The current stock price of ₹45.93 is trading 9.7% below its estimated GF Value™ of ₹50.89.
GuruFocus considers Lykis to be Modestly Undervalued.
Key valuation signals for BOM:530689:
EBITDA Margin %: 3.64% (66% above median its 10-year median of 2.19)
GF Value™: ₹50.89 vs. price of ₹45.93 (9.7% below fair value)
Industry Position: 59.6% below the Consumer Packaged Goods median (#1438 of 1955)
No single metric tells the full story. See the BOM:530689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lykis Ltd is engaged in the business of exporting FMCG, Cosmetics, and other products. Its brands include Lykis, Britex, Rox, Bonita, Lykon, Bentol, Special, and others. The company provides personal care products comprising personal wash, hair care, skincare, and baby care products, as well as deodorants, perfumes, and talcums; home care products consisting of dish wash bars and liquid, floor cleaners, glass cleaners, toilet cleaners, and air fresheners and OTC products, including products for headache, body pain, and foot care products. It operates in the FMCG segment.
67GF Score
Get the complete analysis for BOM:530689
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530689 has been successfully added to your 
